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ABSTRACT: Bacterially induced osteoblast apoptosis may be a major contributor to bone loss during os-
teomyelitis. We provide evidence for the functional expression in osteoblasts of NLRP3, a member of the NLR
family of cytosolic receptors that has been implicated in the initiation of programmed cell death.
Introduction: Osteoblasts undergo apoptosis after exposure to intracellular bacterial pathogens commonly
associated with osteomyelitis. Death of this bone-forming cell type, in conjunction with increased numbers and
activity of osteoclasts, may underlie the destruction of bone tissue at sites of bacterial infection. To date, the
mechanisms responsible for bacterially induced apoptotic osteoblast cell death have not been resolved.
Materials and Methods: We used flow cytometric techniques to determine whether intracellular invasion is
needed for maximal apoptotic cell death in primary osteoblasts after challenge with Salmonella enterica. In
addition, we used real-time PCR and immunoblot analyses to assess osteoblast expression of members of the
nucleotide-binding domain leucine-rich repeat region–containing family of intracellular receptors (NLRs) that
have been predicted to be involved in the induction of programmed cell death. Furthermore, we have used
co-immunoprecipitation and siRNA techniques to confirm the functionality of such sensors in this cell type.
Results: In this study, we showed that invasion of osteoblasts by Salmonella is necessary for maximal induction
of apoptosis. We showed that murine and human osteoblasts express NLRP3 (previously known as CIAS1,
cryopyrin, PYPAF1, or NALP3) but not NLRC4 (IPAF) and showed that the level of expression of this
cytosolic receptor is modulated after bacterial challenge. We showed that osteoblasts express ASC, an adaptor
molecule for NLRP3, and that these molecules associate after Salmonella infection. In addition, we showed
that a reduction in the expression of NLRP3 attenuates Salmonella-induced reductions in the activity of an
anti-apoptotic transcription factor in osteoblasts. Furthermore, we showed that NLRP3 expression is needed
for caspase-1 activation and maximal induction of apoptosis in osteoblasts after infection with Salmonella.
Conclusions: The functional expression of NLRP3 in osteoblasts provides a potential mechanism underlying
apoptotic cell death of this cell type after challenge with intracellular bacterial pathogens and may be a
significant contributory factor to bone loss at sites of infection.
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INTRODUCTION
RECENT STUDIES FROM our laboratory have shown thatosteoblasts exposed to the principle causative agents
of osteomyelitis express an array of soluble and cell surface
molecules that have the potential to promote immune re-
sponses and osteoclast activity at sites of bone infection.(1)
Interestingly, our laboratory and others have shown that
osteoblasts undergo apoptosis after exposure to intracellu-
lar bacterial pathogens commonly associated with osteomy-
elitis.(2,3) As such, inflammatory bone loss during osteomy-
elitis may result from increased numbers and activity of
bone-resorbing osteoclasts at sites of bacterial infection and
the elimination of the cells responsible for new bone matrix
deposition. Whereas a proportion of this bacterially in-
duced cell death seems to be attributable to the autocrine
and/or paracrine actions of osteoblast-derived TNF-related
apoptosis inducing ligand (TRAIL),(3,4) the mechanisms
underlying the majority of the observed apoptosis remain
unclear.
The demonstration that osteoblasts express members of
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ceptors may represent a means by which these cells recog-
nize bacterial pathogens.(5–7) However, our previous stud-
ies have shown that bacterial products, inactivated bacteria,
and invasion defective strains are far less potent than viable
wildtype bacteria at eliciting immune molecule production
by osteoblasts.(6,8–10) Furthermore, Thammasitboon et
al.(11) have shown that bacterial components such as lipo-
polysaccharide (LPS) fail to elicit apoptosis in osteoblasts.
Taken together, these studies suggest that bacterial inva-
sion is required to evoke maximal responses by these cells.
This phenomenon might be explained by our recent dem-
onstration that osteoblasts express NOD1 and NOD2,(12)
two members of the nucleotide-binding domain and leu-
cine-rich repeat region containing family of receptor pro-
teins (NLRs) that can serve as intracellular sensors for bac-
terial peptidoglycans and initiate pro-inflammatory
mediator production.(13,14)
Although NOD1 and NOD2 can initiate, augment, or
reduce inflammatory mediator production by a variety of
cell types,(15) these cytosolic proteins are not widely recog-
nized to participate in the induction of apoptosis. In con-
trast, two other receptors, NLR family CARD domain con-
taining 4 (NLRC4; previously known as Ipaf, Card12, or
CLAN) and NLR family pyrin domain containing 3
(NLRP3; previously known as CIAS1, cryopyrin, PYPAF1,
or NALP3) have been implicated in the induction of cell
death in response to bacteria and/or their components.(16–19)
Both of these molecules can associate with an adaptor
protein, apoptosis-associated speck-like protein (ASC) to
elicit caspase-1 and caspase-8 activation,(20,21) enzymes
that show elevated activity in osteoblasts after bacterial
challenge.(3,22) In this study, we determined the relative
importance of bacterial invasion in the induction of osteo-
blast cell death by the intracellular pathogen, Salmonella.
Furthermore, we studied the functional expression of
NLRP3 and NLRC4 in resting and Salmonella-exposed
cultures of primary murine and human osteoblasts in an
attempt to identify the mechanisms linking intracellular
invasion to bacterially induced cell death.
MATERIALS AND METHODS
NLRP3-deficient mice
NLRP3-deficient mice, backcrossed for six generations
onto a C57BL/6 background, have previously been charac-
terized(17) and were provided to Dr Ting by Millennium.
Isolation and characterization of murine osteoblasts
Primary osteoblast cell cultures were prepared from
BALB/c, C57BL/6, and NLRP3-deficient mouse neonate
calvariae by sequential collagenase-protease digestion as
previously described by our laboratory.(3,4,6–10,12,22–24) Os-
teoblasts isolated in this manner have previously been char-
acterized as being >99% pure cultures as determined by
their distinctive morphology and by the expression of type
I collagen, osteocalcin, alkaline phosphatase, and PTH-
cAMP.(4) All experiments were performed on osteoblasts
grown to the point of confluency in 6-well plates or culture
flasks, and comparisons were made between the treatment
groups in each experimental series to insure equal cell num-
bers.
Normal human osteoblast cultures
Normal human osteoblast cultures (Clonetics, San Diego,
CA, USA) were purchased and propagated as previously
described by our laboratory.(8–10,23,24) These commercially
available cells have previously been characterized as being
authentic osteoblasts.(25)
Exposure of cultured osteoblasts to Salmonella
Osteoblasts were exposed to bacteria as previously de-
scribed by our laboratory.(6–9,12,22) Confluent cell layers of
cells were exposed to the pathogenic Salmonella enterica
serovar typhimurium strain SB300 or Salmonella enterica
serovar typhimurium strain SB136, at the indicated ratios of
bacteria to osteoblasts in growth medium without antibiot-
ics for 45 min at 37°C. After the infection period, cell cul-
tures were washed with PBS and incubated in growth me-
dium with 25 g/ml gentamicin to kill remaining
extracellular bacteria. Salmonella enterica serovar typhimu-
rium strain SB136 is an invasion defective mutant strain of
Salmonella enterica serovar typhimurium strain SB300, be-
cause of a mutation in the invA gene that prevents Salmo-
nella pathogenicity island-1 type III secretion mechanisms.
This attenuated bacterial strain was a kind gift from Dr
Michael C. Hudson at The University of North Carolina at
Charlotte.
Measurement of apoptosis by flow cytometry
Proportions of cells undergoing apoptosis were deter-
mined by monitoring apoptotic volume decreases as
changes in forward and side scatter characteristics during
flow cytometry or by annexin V staining as previously de-
scribed by our laboratory.(3) Briefly, infected and unin-
fected cells were incubated with 0.025% trypsin-0.01%
EDTA for 10 min at 37°C and collected by centrifugation.
Cells were washed with PBS and stained with FITC-
conjugated annexin V (BD Biosciences, San Diego, CA,
USA) before analysis using a FACSCalibur flow cytometer
(Becton Dickinson, San Jose, CA, USA). In some experi-
ments, cells were dual stained with propidium iodide (0.3
g/ml) to distinguish necrotic (dual positive) from apopto-
tic (annexin V positive) populations. In each experiment, a
minimum of 20,000 cells were counted.
DNA laddering
DNA laddering was performed using a Quick Apoptotic
DNA Ladder Detection kit according to the directions pro-
vided by the manufacturer (BioVision, Mountain View,
CA, USA).
Isolation of RNA and PCR
Poly(A)+ RNA was isolated from osteoblasts and re-
verse transcribed as previously described.(3,4,6–10,12,22) Real-
time PCR was performed on the reverse transcribed cDNA
product to determine the expression of mRNA encoding
NLRP3, NLRC4, ASC, and glyceraldehyde 3-phosphate
dehydrogenase (G3PDH) using a SYBR Green approach
essentially as described previously.(26,27) Positive and nega-
tive strand PCR primers used, respectively, were TG-
CAGAAGACTGACGTCTCC and CGTACAGGCAG-
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TAGAACAGTTC to amplify mRNA encoding murine
NLRP3, AGCATGAACGAGGACGTCCT and GAAG-
TACAATGCGCTTGCACA to amplify mRNA encoding
murine NLRC4, GCAGCTGACTTCCTGGTCT and AC-
GACTCCAGATAGTAGCTGACA to amplify mRNA
encoding murine ASC, and TCCTCCTGGTCGGCGCCT
and CCATGTCGCGCAGCACGTT to amplify mRNA
encoding human ASC. PCR primers were derived from the
published sequences of murine NLRP3,(28) NLRC4,(29) and
ASC (accession number: AB032249) and human ASC.(30)
All primers were designed by using Oligo 4.0 primer analy-
sis software (National Biosciences, Plymouth, MA, USA)
based on their location in different exons of the genomic
sequences for NLRP3, NLRC4, and ASC in addition to
their lack of significant homology to other published se-
quences as determined by NCBI Mega BLAST search en-
gine (www.ncbi.nlm.gov/blast).
A Roche Light Cycler 2.0 was used to perform all PCR
reactions, and the expression of NLRP3, NLRC4, and ASC
products was normalized to the level of expression of
mRNA encoding G3PDH determined in parallel PCR re-
actions. The identities of the PCR amplified fragments were
verified by size comparison with DNA standards (Promega,
Madison, WI, USA) and by direct DNA sequencing of rep-
resentative fragments (Davis Sequencing, Davis, CA,
USA).
Quantification of IL-6 secretion in osteoblast
culture supernatants
Specific capture ELISAs were performed to quantify
IL-6 secretion by osteoblasts as described previously by our
laboratory.(7,10,12)
FIG. 1. Invasion-defective Salmonella strains are less effective at inducing apoptosis in osteoblasts. (A) Cells (2 × 106 per well) were
unstimulated or exposed to either Salmonella SB300 or SB136 (m.o.i. of 10 bacteria per cell) for 24 h. Cells were stained with annexin
V-FITC and analyzed by flow cytometry. For comparison purposes, cells were treated with the thapsigargin (THG; 1 M). (B)
Osteoblasts (2 × 106 per well) were unstimulated or exposed to either Salmonella SB300 or SB136 (m.o.i. of 10 bacteria per cell) for
24 h. Cells were dual stained with annexin V-FITC and propidium iodide and analyzed by flow cytometry.
FIG. 2. Bacterial uptake is required for maximal levels of Salmonella-induced apoptosis in osteoblasts. Cells (2 × 106 per well) were
unstimulated or exposed to either Salmonella SB300 (m.o.i. of 1, 3, and 10 bacteria per cell) in the absence or presence of cytochalasin
(5 g/ml) for 24 h. (A) Culture supernatants were assayed for the presence of IL-6 by capture ELISA. (B) The percentage of cells
showing an apoptotic volume decrease after challenge with Salmonella SB300 at an m.o.i. of three bacteria per cell was assessed by flow
cytometry. (C) Cells after challenge with Salmonella SB300 at an m.o.i. of three bacteria per cell were stained with annexin V-FITC
and analyzed by flow cytometry. aSignificant difference between IL-6 production in the presence and absence of cytochalasin (p < 0.05).
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Immunoblot analysis of NLRP3, NLRC4, and ASC
Immunoblot analyses for the presence of NLRP3,
NLRC4, and ASC in osteoblasts were performed as de-
scribed previously by our laboratory.(3,4,6,7,23,24) The pri-
mary antibodies used were a commercially available affinity
purified rabbit polyclonal antibody directed against human
and murine NLR4C (Alpha Diagnostic International), a
rabbit polyclonal antibody directed against human and mu-
rine ASC (Chemicon International, Temecula, CA, USA),
and a rabbit polyclonal anti-serum directed against the
amino terminal of human NLRP3 that is cross-reactive with
murine NLRP3. This anti-serum was developed in Dr
Ting’s laboratory, and its specificity has previously been
documented.(31)
Immunoblot analysis for NF-kB p65 (RelA)
translocation and caspase-1 activation
Activation of the transcriptional activator NF-kB was as-
sessed by nuclear translocation of the p65 subunit (RelA) of
NF-kB by immunoblot analysis of nuclear protein isolates
as described previously by our laboratory.(32) Immunoblot
analysis of caspase-1 activation was performed on whole
cell protein isolates using a commercially available goat
polyclonal antibody directed against mouse cleaved
caspase-1 p10 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA).
Co-immunoprecipitation of NLRP3 with ASC
Co-immunoprecipitation was performed essentially as
described previously by Clark et al.(33) Briefly, cells (2 ×
106) were washed with ice-cold PBS and lysed at 4°C for 2
h in Tris buffered saline with EDTA (150 mM NaCl, 5 mM
EDTA, 20 mM Tris, pH 7.5) plus 1% Brij-97 (Sigma-
Aldrich) and 10 units/ml aprotinin (Calbiochem, San
Diego, CA, USA), 1 mM PMSF, and 1 g/ml pepstatin A.
The lysates were preincubated with protein A agarose
beads (Pierce Endogen) for 1 h before incubation with pro-
tein A agarose beads-conjugated with antibodies directed
against NLRP3 or ASC for 18 h at 4°C. The immunopre-
cipitated material was subsequently subjected to immuno-
blot analysis for the presence of ASC or NLRP3 as de-
scribed above.
Small interfering RNA knockdown of
NLRP3 expression
Knockdown of NLRP3 expression was achieved by trans-
fecting osteoblasts with a combination of two commercially
available small interfering RNAs (siRNAs) against this
molecule (Cias1 Stealth Select RNAi MSS211224 and
MSS211223; Invitrogen, Carlsbad, CA, USA) or a siRNA
directed against an irrelevant RNA species to ensure the
specificity of this knockdown. Osteoblasts were incubated
with these siRNA in the presence of lipofectamine (200
pmol/ml; Invitrogen) for 30 min before removal and wash-
ing. At 24 h after transfection, knockdown of NLRP3 pro-
tein expression was confirmed by immunoblot, and these
cells were used in the experiments described.
Densitometric analyses
Densitometric analyses of immunoblots were performed
using NIH Image (obtained from the NIH Web site: http://
rsb.info.nih.gov/nih-image). Results are presented as mean
values of arbitrary densitometric units corrected for back-
ground intensity and normalized to the expression of -
actin or as fold increases over levels in unstimulated cells.
Statistical analysis
Results of these studies were tested statistically using Stu-
dent’s paired t-test or one-way ANOVA as appropriate us-
ing commercially available software (GraphPad Prism;
GraphPad Software, San Diego, CA, USA). Fluorescence
histograms were directly compared using Kolmogorov-
Smirnov statistics using commercially available software
(CellQuest; Becton Dickinson). Results were determined
to be statistically significant when p < 0.05 was obtained.
RESULTS
Intracellular invasion is required for maximal
Salmonella-induced apoptosis of primary osteoblasts
Our laboratory has previously shown that UV killed Sal-
monella and invasion defective strains of this bacterium
elicit significantly lower inflammatory cytokine production
by primary osteoblasts than viable wildtype Salmonella.(12)
To begin to determine whether bacterial invasion is re-
quired from maximal induction of osteoblast apoptosis, pri-
mary murine cells were exposed to wildtype Salmonella
enterica strain SB300 or the invasion defective strain SB136
and levels of apoptosis were assessed by annexin V staining.
As shown in Fig. 1A, the annexin V-positive population was
significantly elevated (p < 0.05) as early as 24 h after Sal-
monella SB300 exposure. Indeed, this induction was mark-
FIG. 3. Expression of mRNA encoding NLRP3 and NLRC4 in
resting and Salmonella-infected murine osteoblasts. Osteoblasts
(2 × 106 per well) were untreated (0) or exposed to Salmonella
SB300 or SB136 (m.o.i. of 1, 3, and 10 bacteria per cell). RNA was
isolated at 4 h after treatment, and real-time PCR was performed
for the presence of mRNA encoding (A) NLRP3 or (B) NLRC4.
Expression shown is normalized to the expression of mRNA en-
coding G3PDH quantified in parallel real-time PCR reactions.
For comparison purposes, amplification of known quantities of
PCR products is shown (STDS). aSignificant difference in mRNA
expression between uninfected and bacterially challenged osteo-
blasts (p < 0.05).
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edly higher than that induced by an endosomal Ca2+-
ATPase inhibitor, thapsigargin (1 M; Fig. 1A), or serum
starving (data not shown) for the same time period. More
importantly, exposure to SB136 resulted in a significantly
lower percentage of annexin V-positive cells than the
invasive strain (p < 0.05). This effect could not be explained
on the basis of differences in numbers of necrotic cells
because no significant differences were observed in the
population of double positive cells stained with annexin V
and propidium iodide to assess cell membrane integrity
(3% and 5% in SB300 and SB136 treated, respectively)
whereas significant differences were observed in annexin
V-positive–propidium iodide-negative cells (39%, and 25%
in SB300 and SB136 treated, respectively; Fig. 1B). Simi-
larly, osteoblasts exposed to SB300 showed markedly
higher levels of apoptotic cell death than SB136-treated
cells when qualitatively assessed by DNA laddering (data
not shown).
To further assess the relative importance of bacterial in-
vasion in inducing osteoblast apoptosis, cells were exposed
to wildtype bacteria in the presence or absence of the en-
docytosis inhibitor cytochalasin (5 g/ml). As shown in Fig.
2A, cytochalasin significantly inhibited IL-6 production by
osteoblasts exposed to Salmonella. Importantly, this agent
also significantly reduced the proportion of cell showing an
apoptotic volume decrease as shown in the representative
experiment shown in Fig. 2B, with a decrease in this popu-
lation after challenge with Salmonella SB300 at an m.o.i. of
three bacteria per cell from 34.0 ± 6.0% to 23.5 ± 2.6%
(p < 0.05; n  3) in the absence or presence of cytochalasin,
respectively. Furthermore, cytochalasin diminished the an-
nexin V-positive population after bacterial challenge (46%,
and 26% in SB300 and SB136 treated, respectively; p < 0.05;
Fig. 2C). Taken together, these data indicate that invasion
is needed for maximal induction of apoptosis in osteoblasts
after bacterial challenge.
Primary osteoblasts express NLRP3 but not NLRC4
To begin to determine the mechanisms underlying osteo-
blast apoptosis after Salmonella invasion, we studied
whether these cells express mRNA encoding either NLRP3
or NLRC4. Murine osteoblasts were untreated or exposed
to Salmonella SB300 or SB136 at varying numbers of bac-
teria to cells before isolation of RNA at 4 h after infection.
As shown in Fig. 3A, resting osteoblasts expressed low but
detectable levels of mRNA encoding NLRP3 as deter-
mined by quantitative real-time PCR. Interestingly, inva-
sive but not invasion-defective strains of Salmonella elicited
rapid and marked increases in NLRP3 mRNA expression
in a dose-dependent manner (Fig. 3A). The identity of the
PCR products was confirmed by comparison of the migra-
tion of products with those of known size by agarose gel
electrophoresis and by direct sequencing (Davis Sequenc-
ing). In contrast, mRNA encoding NLRC4 was not detect-
able in either resting or bacterially challenged osteoblasts
(Fig. 3B).
To confirm that the expression of mRNA encoding
NLRP3 results in protein expression, we performed immu-
noblot analyses using antibodies previously developed to
show specificity for NLRP3.(31) As shown in Fig. 4A, un-
stimulated murine osteoblasts express robust levels of a
protein that migrated to the predicted molecular size of
NLRP3 (120 kDa). Exposure of murine cells to invasive
Salmonella elicited only modest elevations in total cellular
NLRP3 content at 24 h after infection (Fig. 4A) despite the
marked elevations in mRNA (Fig. 3A). Interestingly, and in
contrast to SB300, challenge of osteoblasts with non-
invasive SB136 Salmonella elicited significant (p < 0.05)
reductions in NLRP3 expression by almost 50% (Fig. 4A).
This effect was similarly observed in primary human osteo-
blasts, in which robust NLRP3 expression was reduced after
exposure to invasion defective Salmonella (data not
shown).
To confirm our real-time PCR data indicating that osteo-
blasts do not express NLRC4 either constitutively or after
bacterial challenge, protein isolates were probed for the
presence of this NLR by immunoblot analysis. As shown in
Fig. 4B, no significant expression of NLRC4 was detectable
FIG. 4. Expression of NLRP3 protein but not NLRC4 in resting and Salmonella-infected murine osteoblasts. Cells (2 × 106 per well)
were untreated (0) or exposed to Salmonella SB300 or SB136 (m.o.i. of 1, 3, and 10 bacteria per cell). After 24 h, protein isolates were
subjected to immunoblot analysis for (A) NLRP3 or (B) NLRC4 expression. Representative immunoblots from four separate experi-
ments are shown. Migration of protein standards of known size is indicated to the right. As a positive control for NLRC4 expression,
a spleen total protein isolate was also analyzed (SPL). Below, densitometric analyses of the immunoblot protein bands is shown as
arbitrary densitometric units corrected for background intensity and normalized to -actin expression.
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in either resting or bacterially challenged osteoblasts,
whereas this protein was detectable in murine splenocyte
protein isolates.
Osteoblasts functionally express an important
adaptor molecule for NLRP3 signaling
To begin to determine whether osteoblasts can express
functional NLRP3 cytosolic receptors, we studied whether
these cells express ASC, an important adaptor molecule in
NLRP3-mediated cellular responses.(15,17) Real-time PCR
was performed and revealed that resting murine osteoblasts
(2 × 106 cells) express robust levels of mRNA encoding
ASC (1.1 ± 0.4 copies × 105). Such mRNA expression re-
sults in the presence of low but detectable levels of ASC
protein as determined by immunoblot analysis (Fig. 5A).
Furthermore, cells exposed to Salmonella (1, 3, and 10 bac-
teria per cell) showed significant elevations (p < 0.05) in
NLRP3 protein expression at 24 h after infection (Fig. 5A).
Similarly, low level ASC protein expression in primary hu-
man osteoblasts was markedly elevated after infection with
Salmonella (Fig. 5B).
The constitutive expression of the critical adaptor mol-
ecule ASC and the sensitivity of its expression to bacterial
challenge provide circumstantial evidence for the function-
ality of NLRP3 in osteoblasts. To further study whether
these molecules form a functional component in the re-
sponses of osteoblasts to bacterial infection, we used co-
immunoprecipitation techniques to determine if NLRP3 in-
teracts with ASC in cells after challenge with Salmonella.
Murine osteoblasts were unstimulated or exposed to Sal-
monella (3 and 10 bacteria to each osteoblast), and 2 h after
infection, whole cell protein isolates were subjected to im-
munoprecipitation directed against ASC or NLRP3 and
subsequently analyzed by denaturing immunoblot for the
presence of NLRP3 or ASC, respectively. As shown in Fig.
5C, infection with Salmonella elicited marked elevations in
the amount of NLRP3 associated with ASC as determined
by both co-immunoprecipitation approaches.
NLRP3 mediates cellular responses in
primary osteoblasts
NLRP3 has previously been shown to mediate reductions
in the activity of NF-kB,(31) a transcription factor with anti-
FIG. 5. Osteoblasts functionally express the NLRP3 adaptor
molecule, ASC. (A) Murine or (B) human osteoblasts (2 × 106 per
well) were untreated (0) or exposed to Salmonella SB300 (m.o.i.
of 1, 3, and 10 bacteria per cell). After 24 h, protein isolates were
subjected to immunoblot analysis for ASC expression. Represen-
tative immunoblots from three separate experiments are shown.
As a positive control for ASC expression, a murine thymus total
protein isolate was also analyzed (THY). Below, densitometric
analyses of the immunoblot protein bands is shown as arbitrary
densitometric units corrected for background intensity and nor-
malized to -actin expression. (C) Murine osteoblasts (2 × 106 per
well) were untreated (0) or exposed to Salmonella SB300 (m.o.i.
of 3 and 10 bacteria per cell). After 2 h, protein isolates were
immunoprecipitated with antibodies directed against ASC or
NLRP3 and subsequently analyzed by denaturing immunoblot for
the presence of NLRP3 (top panel) or ASC (bottom panel), re-
spectively. Migration of protein standards of known size is indi-
cated to the right. As a negative control, samples exposed to
immunoprecipitation procedure in the absence of antibodies
against either NLRP3 or ASC and run on the same immunoblots
are shown (proA). These experiments were performed twice with
similar results.
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apoptotic activity.(34–36) As shown in Fig. 6A, uninfected
cultured osteoblasts exhibit robust NF-kB activity as as-
sessed by nuclear levels of the RelA p65 subunit. Interest-
ingly, exposure to Salmonella elicits dose-dependent reduc-
tions in NF-kB activity (Fig. 6A). To confirm the functional
status of NLRP3 in osteoblasts, we used siRNA techniques
to knockdown the expression of this cytosolic protein. As
shown in the representative immunoblot in Fig. 6B, trans-
fection of primary murine osteoblasts with siRNA
for NLRP3 elicits an ∼54% reduction in cellular NLRP3
levels. Importantly, transfection of osteoblasts with siRNA
against NLRP3 markedly attenuates bacterially induced re-
ductions in NF-kB activity (Fig. 6C), indicating that the
ability of Salmonella to diminish the activity of this anti-
apoptotic factor is caused, in large part, by the presence of
NLRP3.
NLRP3 is required for caspase-1 activation and
maximal Salmonella-induced apoptosis of
primary osteoblasts
We have previously shown that caspase-1 activity is el-
evated in osteoblasts after bacterial challenge.(22) To defini-
tively establish a role for NLRP3 in bacterially induced
osteoblast cell death, we studied caspase-1 activation and
apoptosis in cells derived from animals genetically deficient
in the expression of this molecule. Caspase-1 processing is
induced in osteoblasts as shown by the appearance of the
active caspase-1 p10 subunit and the caspase-1 activation
intermediate, p45, as rapidly as 4 h after infection (data not
shown) with a maximal induction at 8 h after challenge (Fig.
7A). In contrast, caspase-1 processing is absent in osteo-
blasts derived from NLRP3-deficient mice (NLRP3−/−; Fig.
7A). We have previously shown that infected osteoblasts do
not release the caspase-1–dependent cytokines IL-1 and
IL-18,(22) but we found that the production of IL-6 by
NLRP3−/− cells is significantly lower than that produced by
equal numbers of strain matched NLRP3+/+ osteoblasts (5.5
± 0.2 versus 7.6 ± 0.5 ng/ml, respectively, after 24-h Salmo-
nella infection at an m.o.i. of 3:1 bacteria to osteoblasts; p <
0.05). Currently, the mechanism underlying this effect is not
apparent.
Finally, we assessed the relative importance of NLRP3 to
the induction of apoptotic cell death in Salmonella-infected
osteoblasts. As shown in the representative experiment in
Fig. 7B, significantly fewer NLRP3−/− osteoblasts undergo
apoptotic cell death after Salmonella challenge (3:1 bacteria
to each osteoblast) than strain-matched NLRP3+/+ cells as
assessed by apoptotic volume decrease. The population of
apoptotic cells after infection was 19.3 ± 1.2% versus 30.7 ±
1.9 to at an m.o.i. of 3:1 (p < 0.05; n  4), and 25.9 ± 1.8
versus 43.1 ± 2.3 at an m.o.i. of 10:1 (p < 0.05; n  4) in
NLRP3−/− cells and NLRP3+/+ cells, respectively. Taken
together, these data indicate that NLRP3 plays a significant
role in the initiation of cell death in bacterially challenged
osteoblasts.
DISCUSSION
Osteomyelitis is an intractable and persistent inflamma-
tory disease resulting from bacterial infection of bone tis-
sue. Whereas the increasing incidence and severity of os-
teomyelitis may be caused by the emergence of antibiotic-
resistant strains of the bacteria commonly associated with
this condition, the persistence and recurrent nature of such
infections may stem from the ability of causative agents to
invade and reside within bone-forming osteoblasts. Inter-
nalization may provide a means of protection against neu-
trophil and antibody-mediated immune responses, and may
mitigate therapeutic interventions by limiting exposure to
antibiotics. For example, Salmonella species are intracellu-
lar bacterial pathogens that represent one of the most seri-
ous pathogens of bone in sickle cell patients and immuno-
suppressed patients.(37–39) This organism is well known for
its ability to invade epithelial cells,(40–42) and we showed
that this bacterium can invade primary osteoblasts.(8)
Bacteria and their products can be potent stimulators of
FIG. 6. NLRP3 mediates the ability of Salmonella to decrease NF-kB activity in primary murine osteoblasts. (A) Osteoblasts (2 × 106
per well) were untreated (0) or exposed to Salmonella SB300 (m.o.i. of 1, 3, and 10 bacteria per cell). After 1 h, nuclear protein isolates
were subjected to immunoblot analysis for the p65 subunit of NF-kB (RelA). A representative immunoblot from four separate
experiments is shown. (B) Expression of NLRP3 or an irrelevant protein (IRR) in osteoblasts that were untreated (labeled C) or 24
h after transfection with siRNA against NLRP3 (P3) or two siRNA against irrelevant RNA species (IR1 and IR2). The immunoblot
shown is representative of four experiments. (C) Osteoblasts transfected with siRNA against NLRP3 (P3) or an irrelevant RNA species
(IR1) were untreated (0) or exposed to Salmonella SB300 (m.o.i. of 1, 3, and 10 bacteria per cell) for 1 h, and nuclear protein isolates
were analyzed for NF-kB p65 subunit (RelA) content. This experiment was performed twice with similar results.
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bone destruction at sites of infection.(43) Bone loss at such
sites may result from increased formation and function of
bone-resorbing osteoclasts, and we documented the ability
of bacterially challenged osteoblasts to produce an array of
soluble inflammatory mediators that can promote osteo-
clastogenesis and osteoclast activity.(1) Importantly, the de-
struction of bone-forming osteoblasts would be expected to
exacerbate bone loss, and laboratories including our own
have shown that these cells undergo apoptosis after bacte-
rial challenge.(2,3) In this study, we confirmed that Salmo-
nella enterica can elicit significant apoptotic cell death as
rapidly at 24 h after infection. Importantly, we showed that
intracellular invasion is needed for maximal induction of
apoptosis in this cell type as shown by the sensitivity of this
response to a pharmacologic inhibitor of endocytosis and
the significantly smaller apoptotic response to invasion-
deficient Salmonella strains (Figs. 1 and 2).
We have previously shown that bacterial components,
UV-inactivated bacteria, and invasion-defective strains of
bacteria are less effective in eliciting the immune functions
of osteoblasts than viable wildtype bacteria.(6,8–10,12) Con-
sistent with these findings, this study showed that cytocha-
lasin significantly attenuates inflammatory cytokine pro-
duction by invasive Salmonella. These observations indicate
that invasion is required for optimal osteoblast responses
and suggest that the cell surface TLRs expressed by these
cells(5–7) are not the only means by which these cells per-
ceive bacterial pathogens. We recently studied the expres-
sion by osteoblasts of NOD1 and NOD2, members of the
NLR family of cytosolic receptors that have been shown to
mediate inflammatory immune responses in other cell
types, and showed that these resident bone cells expressed
both of these receptors after bacterial challenge.(12) How-
ever, neither of these NLR family members is widely rec-
FIG. 7. NLRP3 is required for caspase-1 activation and maximal induction of apoptosis in osteoblasts after challenge with Salmonella.
(A) Osteoblasts (2 × 106 per well) derived from wildtype (NLRP3+/+) or animals genetically deficient in the expression of NLRP3
(NLRP3−/−) were untreated (0) or exposed to Salmonella SB300 (m.o.i. of 1, 3, and 10 bacteria per cell). After 8 h, protein isolates were
subjected to immunoblot analysis for caspase-1. A representative immunoblot from three separate experiments is shown. Bands
corresponding to the active caspase-1 p10 subunit and the caspase-1 activation intermediate, p45, are indicated. As a positive control
for caspase-1 activation, a total protein isolate from stimulated macrophages was also analyzed (m). (B) Osteoblasts (2 × 106 per well)
derived from wildtype (NLRP3+/+) or animals genetically deficient in the expression of NLRP3 (NLRP3−/−) were unstimulated or
exposed to Salmonella SB300 (m.o.i. of 10 bacteria per cell). After 24 h, the percentage of cells showing an apoptotic volume decrease
was assessed by flow cytometry. The data shown are representative of four experiments.
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ognized to mediate the induction of apoptosis. In contrast,
NLRP3 and NLRC4 have been implicated in caspase acti-
vation(17–19,44,45) and the initiation of apoptosis.(16,17,19) In
this study, we showed that osteoblasts constitutively express
NLRP3 but not NLRC4. Interestingly, infection of these
cells with Salmonella elicits significantly elevations in
mRNA encoding NLRP3 that is associated with the main-
tenance and perhaps a modest elevation of NLRP3 protein
expression in contrast with the significant decrease seen
after exposure of osteoblasts to an invasion-defective strain.
In addition to showing that osteoblasts possess robust
constitutive levels of NLRP3, we showed that these cells
also express ASC, an adaptor molecule that has been shown
to mediate the actions of NLRP3.(16,19,44–46) Whereas con-
stitutive levels of ASC seem to be low in resting osteoblasts,
robust elevations in expression were observed in cells after
Salmonella infection. Taken together, the conserved ex-
pression of NLRP3 and ASC in both mouse and human
osteoblasts, and the sensitivity of such expression to bacte-
rial challenge provide circumstantial evidence of a role for
these cytosolic proteins in osteoblast responses to intracel-
lular pathogens. However, we more directly verified
NLRP3 functionality in bacterially challenged osteoblasts.
First, we showed that NLRP3 associates with ASC after
exposure to Salmonella as determined by co-immunopre-
cipitation. Second, we showed that NLRP3 expression
knockdown by siRNA attenuates Salmonella-induced
changes in transcription factor activity. Third, we found that
osteoblasts derived from NLRP3-deficient animals produce
lower amounts of an inflammatory cytokine than cells de-
rived from wildtype mice. As such, these findings confirm
that NLRP3 mediates osteoblast responses to this intracel-
lular bacterial pathogen.
Our previous studies using blocking antibodies have
shown that some osteoblast cell death is attributable to the
autocrine and/or paracrine actions of TRAIL that is se-
creted by these cells after bacterial exposure.(3,4) However,
a large proportion of this apoptotic cell death is unaffected
by anti-TRAIL antibodies.(3) Given that osteoblasts consti-
tutively express NLRP3 and ASC, and the finding that
NLRP3 can associate with ASC to elicit caspase-1(16,19,44,45)
and perhaps caspase-8 activation,(21) enzymes that show el-
evated activity in osteoblasts after bacterial challenge,(3,22)
this cytosolic NLR may represent an important mechanism
underlying apoptosis of osteoblasts after exposure to intra-
cellular bacterial pathogens. This hypothesis is supported
by the observation that Salmonella-induced decreases in
NF-kB activity are markedly attenuated in osteoblasts after
siRNA-induced NLRP3 knockdown, because this tran-
scription factor has been reported to be anti-apoptotic in a
variety of cell types.(34–36) Furthermore, we showed that
Salmonella-induced caspase-1 activation is absent in osteo-
blasts derived from NLRP3-deficient animals. More impor-
tantly, we showed that such cells exhibit significantly less
apoptotic cell death after Salmonella infection than osteo-
blasts derived from wildtype animals. These data differ
from findings in macrophages(18,19) where NLRP3 is not
needed for Salmonella-induced caspase-1 activation, IL-1
production, or cell death. Instead, these functions are
prominently mediated by NLRC4. In our work, NLRP3 is
required for caspase-1 activation and for a portion of Sal-
monella-induced cell death in osteoblasts, whereas NLRP4
is not detectable in these cells and is thus unlikely to play a
role. Furthermore, earlier work from our laboratory indi-
cates that neither the precursor nor the mature form of
IL-1 is produced by infected osteoblasts.(22) Together
these studies underscore the differences between osteo-
blasts and macrophages with a differential reliance on
NLRP3 versus NLRC4 after Salmonella infection. This il-
lustrates an additional level of complexity in the control of
cellular functions by NLR family members.
Although further experimentation will be required to de-
finitively conclude that ASC and alterations in NF-kB ac-
tivity are essential mechanistic elements in NLRP3-
mediated apoptosis in bacterially challenged osteoblasts,
this study indicates that this NLR represents an important
component underlying the initiation of apoptosis in this
bone-forming cell type after challenge with intracellular
bacterial pathogens and could, therefore, be a major con-
tributory factor to bone loss at sites of infection.
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